Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
Clinical trial NCT03568994 · COMPLETED
Trial details
- NCT number
- NCT03568994
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-09-29
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.